Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 61,652 shares at $129.10 ($7.8M) on 2023-09-11, disclosed to the SEC on 2023-09-12.
Scheduled sale ($7.8M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.23 | 5,007 | $627K | 8.0% |
| 2 | $125.23 | 5,008 | $627K | 8.0% |
| 3 | $125.23 | 5,008 | $627K | 8.0% |
| 4 | $125.23 | 5,007 | $627K | 8.0% |
| 5 | $126.17 | 5,452 | $688K | 8.8% |
| 6 | $126.17 | 5,452 |
| $688K |
| 8.8% |
| 7 | $127.18 | 1,873 | $238K | 3.0% |
| 8 | $127.18 | 1,873 | $238K | 3.0% |
| 9 | $127.18 | 1,874 | $238K | 3.0% |
| 10 | $127.18 | 1,874 | $238K | 3.0% |
| 11 | $128.37 | 10,557 | $1.4M | 17.3% |
| 12 | $128.37 | 10,557 | $1.4M | 17.3% |
| 13 | $129.10 | 2,110 | $272K | 3.5% |
| Total | $126.84 avg | 61,652 | $7.8M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |